Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taïdo is a topical gynecological gel developed by Laboratoire des Réalisations Thérapeutiques ELERTE, specifically formulated to address vulvovaginal dryness and associated discomfort. As a non-hormonal lubricant and moisturizer, it is composed of ingredients such as glycerol and marine collagen, which work to restore hydration and maintain the elasticity of the vaginal mucosa. Taïdo is indicated for women experiencing dryness due to menopause, hormonal fluctuations, or medical treatments that cause mucosal dehydration. It is designed to alleviate symptoms of irritation and facilitate comfortable sexual activity (dyspareunia). While often categorized as a cosmetic or a medical device in various jurisdictions, it is a standard non-pharmacological option for managing gynecologic disorders related to mucosal dryness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Taïdo.